Centrum Medyczne ENEL-MEDWAR:ENE 77 Return-on-Tangible-Equity is 2.35% as of Mar. 2026. GuruFocus rates WAR:ENE with a GF Score™ of 77/100 and a GF Value™ of zł25.07 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 580 Healthcare Providers & Services companies, Centrum Medyczne ENEL-MED ranks worse than 63.79% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Centrum Medyczne ENEL-MED's annualized net income for the quarter that ended in Mar. 2026 was zł3.9 Mil. Centrum Medyczne ENEL-MED's average shareholder tangible equity for the quarter that ended in Mar. 2026 was zł165.1 Mil. Therefore, Centrum Medyczne ENEL-MED's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 2.35%.
The historical rank and industry rank for Centrum Medyczne ENEL-MED's Return-on-Tangible-Equity or its related term are showing as below:
WAR:ENE'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -16.11 Med: -0.92 Max: 10.13
Current: 4.77
During the past 13 years, Centrum Medyczne ENEL-MED's highest Return-on-Tangible-Equity was 10.13%. The lowest was -16.11%. And the median was -0.92%.
WAR:ENE's Return-on-Tangible-Equity is ranked worse than 63.79% of 580
companies
in the Healthcare Providers & Services industry
Industry Median: 10.065
vs WAR:ENE: 4.77
Centrum Medyczne ENEL-MED (WAR:ENE) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Centrum Medyczne ENEL-MED Return-on-Tangible-Equity Related Terms
Centrum Medyczne ENEL-MED Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Centrum Medyczne ENEL-MED's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Centrum Medyczne ENEL-MED Return-on-Tangible-Equity Chart
WAR:ENE vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Centrum Medyczne ENEL-MED's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Centrum Medyczne ENEL-MED Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Centrum Medyczne ENEL-MED's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Centrum Medyczne ENEL-MED's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 2.35% mean?
Centrum Medyczne ENEL-MED (WAR:ENE) has a Return-on-Tangible-Equity of 2.35% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Centrum Medyczne ENEL-MED and its competitors. According to the industry distribution chart, Centrum Medyczne ENEL-MED ranks #370 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 63.8%.
Is Centrum Medyczne ENEL-MED's Return-on-Tangible-Equity too high?
Centrum Medyczne ENEL-MED's current Return-on-Tangible-Equity is 2.35%. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.07. Centrum Medyczne ENEL-MED's value of 2.35% is 76.7% below this industry median. Based on the distribution chart, Centrum Medyczne ENEL-MED ranks #370 out of 580 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Centrum Medyczne ENEL-MED has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Centrum Medyczne ENEL-MED's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Centrum Medyczne ENEL-MED ranks #370 out of 580 companies for Return-on-Tangible-Equity. This places Centrum Medyczne ENEL-MED in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.07. Centrum Medyczne ENEL-MED's value of 2.35% is 76.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.07, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Centrum Medyczne ENEL-MED's current Return-on-Tangible-Equity of 2.35% is 76.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Centrum Medyczne ENEL-MED and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Centrum Medyczne ENEL-MED's current Return-on-Tangible-Equity is 2.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centrum Medyczne ENEL-MED stock overvalued right now?
Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED (WAR:ENE) is currently considered Modestly Undervalued. The stock's GF Value™ is zł25.07, compared to a current price of zł19.00 — trading 24.2% below its estimated fair value. The current Return-on-Tangible-Equity is 2.35% and 76.7% below the Healthcare Providers & Services industry median of 10.07. Centrum Medyczne ENEL-MED's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Centrum Medyczne ENEL-MED (WAR:ENE), the current Return-on-Tangible-Equity is 2.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Centrum Medyczne ENEL-MED (WAR:ENE) Overvalued in 2026?
Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED stock appears to be undervalued.
The current stock price of zł19.00 is trading 24.2% below its estimated GF Value™ of zł25.07.
GuruFocus considers Centrum Medyczne ENEL-MED to be Modestly Undervalued.
Key valuation signals for WAR:ENE:
Return-on-Tangible-Equity: 2.35%
GF Value™: zł25.07 vs. price of zł19.00 (24.2% below fair value)
Industry Position: 76.7% below the Healthcare Providers & Services median (#370 of 580)
No single metric tells the full story. See the WAR:ENE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Centrum Medyczne ENEL-MED SA is engaged in providing medical services throughout Poland region. The company is involved in providing various services that are dentistry, picture diagnosis, clinics, subscription for companies, and medical insurance. It also provides hospitals, aesthetic medicines, and sports medicine. The company's treatment cycle consists of consultation, diagnosis, hospitalization, surgery, and rehabilitation.
77GF Score
Get the complete analysis for WAR:ENE
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:ENE has been successfully added to your 
